The beneficial effects of ultramicronized palmitoylethanolamide in the management of neuropathic pain and associated mood disorders induced by paclitaxelin mice

HIGHLIGHTS

  • who: Claudia Cristiano et al. from the Department of Pharmacy, University of Naples Federico II, Via DMontesano, Naples, Italy have published the research work: The Beneficial Effects of Ultramicronized Palmitoylethanolamide in the Management of Neuropathic Pain and Associated Mood Disorders Induced by Paclitaxelin Mice, in the Journal: Biomolecules 2022, x of /2022/
  • what: The aim of this work is to investigate whether the palmitoylethanolamide (PEA) would reduce PTX-induced CIPN and associated mood disorders. The aim of the study was to investigate the activity of PEA on two PTX-induced side effects, i.e., mood . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?